Brussels Metropolitan Area
Results oriented; I identify growth markets for biopharma services; test new technologies, and confirm value with KOLs, in order to provide new high value-added services to drug development companies. 25 years strategic and on the ground product launch, sales and marketing experience in GMP plasmid, mRNA and recombinant protein CDMO services. Significant track record in providing professional and concrete solutions to biopharma companies via high value-added services, increasing sales more than 4x. Strategic, ability to see around corners, while maintaining intellectual honesty. A high sense of urgency with a can do attitude. Consistent fruitful collaborations with cross-functional teams.
Founding new department responsible for identifying growth opportunities in the biopharma sector, providing strategic options and bringing the most promising to market in collaboration with cross-functional teams. • Value chain mapping, • Voice of market surveying, • Value proposition consolidation, • Cross-functional collaboration with technical, laboratory, BD, production and legal teams, • Pre-launch package preparation, • Service kick-off.
BD director with a proven track record in CDMO business development and team management. • Deep understanding of drug development CMC activities in plasmid DNA, mRNA, and recombinant protein (eg VHH, enzymes, cytokines, antigens) production for human clinical and commercial use • Accountable for BD activities linked to GMP biomanufacturing services, sales strategy, marketing strategy, BD team management, expansion opportunities, go-to-market, and contract negotiations for clinical and commercial manufacturing. • Manage a team of 4 Business Developers • Reporting to Site Head and CEO.
Major Accomplishments: • Established big pharma customer base • Sales process definition, KPI automation, CRM optimization, business process trends analysis • Positioning Eurogentec as a world-class GMP Plasmid DNA manufacturer • Positioning Eurogentec as a world-class GMP Pichia pastoris based recombinant protein manufacturer • Double digit millions of EUR in sales each year Role: • Dual role (i) Management of a team of Biologics Account Managers (ii) Operational Sales / BD on worldwide basis (EU, US, JP), particularly to Big Pharma • Client-side interactions with CEO's, CSO's, Heads of CMC, Head of Quality Assurance, Project Managers, Purchasing and External Sourcing • Internal team work in a multidisciplinary environment with partners in Project Management, Process Development, GMP manufacturing, QC, QA, and Legal • Report to Executive Vice President and VP Biologics • Member of the Biologics Business Unit Management Team • 25-30% international travel
WITA Proteomics GmbH was acquired by Eurogentec SA. 2D gel electrophoresis, differential analysis and protein identification services. Primary customers – Biomarker and target identification groups in pharmaceutical companies. Design/Supervision of web site, conference stand, brochures, promotional material, press releases, business development support.
Start-up company offering 2D gel electrophoresis, differential analysis and protein identification services. Primary customer – Biomarker and target identification groups in pharmaceutical companies. WITA Proteomics was purchased by Eurogentec SA in December 2002. Design/Supervision of web site, conference stand, brochures, promotional material, press releases, business development support.
Product research and development: modified nucleosides for sequencing applications